Question

Is stem cell therapy for Primary Immunodeficiency covered by insurance?

Coverage is diagnosis-, transplant-, centre- and policy-specific. Obtain written approval for donor testing, conditioning, admission, medicines, monitoring and complications; coverage of HSCT does not extend automatically to an unrelated commercial product.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The cost picture for Primary Immunodeficiency

Separate diagnostic genetics, donor search, product procurement, conditioning, admission, infection prophylaxis, long-term follow-up and complication care. Obtain a transplant centre and insurer decision for the exact diagnosis or a sponsor statement for a trial. Do not compare this pathway with a same-day commercial infusion by price alone.

Am I a candidate? → · Primary Immunodeficiency: full overview → · Primary Immunodeficiency cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information